| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 387 | 2020 |
| Rice nucleosome patterns undergo remodeling coincident with stress-induced gene expression Q Zhang, DH Oh, SF DiTusa, MV RamanaRao, N Baisakh, ... BMC genomics 19, 1-16, 2018 | 15 | 2018 |
| 从污染物微核检测实验分析实验误差原因 张琦， 杨先泉 生物学通报 46 (10), 57-59, 2011 | 4 | 2011 |
| A high sensitivity, tumor-informed liquid biopsy platform, designed to detect minimal residual disease at part per million resolution SM Boyle, G Bartha, J Lyle, J Harris, J Northcott, D Norton, RM Pyke, ... Cancer Research 82 (12_Supplement), 5163-5163, 2022 | 3 | 2022 |
| Analytical Validation of NeXT Personal (R), an Ultra-sensitive Personalized Circulating Tumor DNA Assay J Northcott, G Bartha, J Harris, C Li, FCP Navarro, RM Pyke, M Hong, ... medRxiv, 2024.01. 17.23299863, 2024 | 1 | 2024 |
| Large healthy donor dataset demonstrates high analytical specificity and repeatability for the NeXT Personal molecular residual disease assay. F Navarro, G Bartha, J Lyle, J Harris, J Northcott, D Norton, RM Pyke, ... Journal of Clinical Oncology 41 (16_suppl), e15031-e15031, 2023 | | 2023 |
| Analytical performance of an ultra-sensitive, tumor-informed liquid biopsy platform for molecular residual disease detection and clinical guidance R Chen, G Bartha, J Lyle, J Harris, SM Boyle, J Northcott, D Norton, ... Cancer Research 83 (7_Supplement), 3381-3381, 2023 | | 2023 |
Dong-Ha OhComputercraft, NCBI [C]Verified email at ncbi.nlm.nih.gov
